TD SYNNEX director sells 336 SNX shares at $155.79 under 10b5-1
TD SYNNEX (SNX) reported an insider transaction by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 336 | $155.79 | $52K |
Footnotes (1)
- F1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trade was reported for SNX?
Was the SNX trade under a 10b5-1 plan?
What is the insider’s relationship to TD SYNNEX?
Were any derivative securities involved?
Was the ownership direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.